Vacuum-Assisted Breast Biopsy Device Market Size, Share, Growth Analysis, By Procedure(Tethered, Untethered), By Product(Vacuum-Assisted Biopsy Systems, Vacuum-Assisted Biopsy Needles), By Type(9-12G, <9G, <12G), By Technique(Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, MRI-Guided Biopsy, Others), By End User(Hospitals, Academic, Research Institutes, Diagnostic), By Region - Industry Forecast 2024-2031

Vacuum-Assisted Breast Biopsy Device Market Driver

High accuracy of Vacuum-assisted breast biopsy (VABB) devices is anticipated to drive the market growth

• Vacuum-assisted breast biopsy (VABB) devices are gaining immense popularity over conventional biopsy methods because of their ability to obtain large number of tissues with contiguous specimens, the possibility of acquiring multiple specimens with single insertion of a needle, a more accurate diagnosis with a lower cancer miss rate and lower histological underestimates. Apart from the diagnostic indications, VABB is also a recognized method of therapeutic removal of benign lesions such as fibroadenomas. The use of percutaneous VABB can reduce the need for open surgical biopsy or excision, and minimize costs of the operating theatre or hospital stays associated with surgical excision. Hence, all of these factors are driving the growth of Vacuum-assisted breast biopsy (VABB) devices.

Vacuum-Assisted Breast Biopsy Device Market Restraint

High cost of VABB devices

The use of VABB is associated with a higher capital cost such as vacuum generators and biopsy hand-pieces as well as a higher running cost of the consumables, including needles, tubing and localizing markers. Due to its higher cost when compared to Fine needle aspiration (FNA) biopsy or core biopsy, VABB is often used as a second line of biopsy in some hospitals and research centers. In such circumstances, VABB is only conducted after inadequate or inconclusive cytology or histology, or when previous FNA or core biopsies yielded contradictory imaging-pathology results.